Clavreul, A.; Lemée, J.-M.; Soulard, G.; Rousseau, A.; Menei, P.
A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide. Cancers 2021, 13, 5778.
https://doi.org/10.3390/cancers13225778
AMA Style
Clavreul A, Lemée J-M, Soulard G, Rousseau A, Menei P.
A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide. Cancers. 2021; 13(22):5778.
https://doi.org/10.3390/cancers13225778
Chicago/Turabian Style
Clavreul, Anne, Jean-Michel Lemée, Gwénaëlle Soulard, Audrey Rousseau, and Philippe Menei.
2021. "A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide" Cancers 13, no. 22: 5778.
https://doi.org/10.3390/cancers13225778
APA Style
Clavreul, A., Lemée, J.-M., Soulard, G., Rousseau, A., & Menei, P.
(2021). A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide. Cancers, 13(22), 5778.
https://doi.org/10.3390/cancers13225778